Please use this identifier to cite or link to this item:
|Type:||Artigo de periódico|
|Title:||Compatibility and stability of valsartan in a solid pharmaceutical formulation|
|Abstract:||Valsartan (VAL) is a highly selective blocker of the angiotensin II receptor that has been widely used in the treatment of hypertension. Active pharmaceutical ingredient compatibility with excipients (crospovidone, hypromellose, magnesium stearate, microcrystalline cellulose and titanium dioxide) is usually evaluated in solid pharmaceutical development. Compatibility and stability can be evaluated by liquid chromatography. Studies were performed using binary mixtures of 1: 1 (w/w) VAL/excipient; samples were stored under accelerated stability test conditions (40 degrees C at 75% relative humidity). The results indicate that VAL is incompatible with crospovidone and hypromellose, which reduced the VAL content and gave rise to new peaks in the chromatogram due to degradation products.|
Differential Scanning Calorimetry/drug analysis
High performance liquid chromatography/quantitative analysis Pharmaceutical formulations/quantitative analysis
|Editor:||Univ Sao Paulo, Conjunto Quimicas|
|Appears in Collections:||Unicamp - Artigos e Outros Documentos|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.